Please use this identifier to cite or link to this item:
http://hdl.handle.net/11375/17046Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | O'Brien, Bernie J. | en_US |
| dc.contributor.author | Buxton, Martin. | en_US |
| dc.contributor.author | Rushby, Julia A. | en_US |
| dc.contributor.author | Centre for Health Economics and Policy Analysis | en_US |
| dc.date.accessioned | 2015-04-14T14:41:59Z | - |
| dc.date.available | 2015-04-14T14:41:59Z | - |
| dc.date.issued | 1991 | en_US |
| dc.identifier.uri | http://hdl.handle.net/11375/17046 | - |
| dc.description | Bernie J. O'Brien, Martin J. Buxton, Jula A. Rushby. | en_US |
| dc.description | Includes bibliographical references (p. 17-18). | en_US |
| dc.format.extent | 19 p. | en_US |
| dc.publisher | McMaster University | en_US |
| dc.relation.ispartofseries | CHEPA working paper series no. 91-11 | en_US |
| dc.subject | Cost-Benefit Analysis | en_US |
| dc.subject | Defibrillators, Implantable | en_US |
| dc.subject | Defibrillators, Implantable | en_US |
| dc.subject | economics | en_US |
| dc.subject | Electric Countershock | en_US |
| dc.subject | economics | en_US |
| dc.subject | Amiodarone | en_US |
| dc.subject | therapeutic use | en_US |
| dc.subject | Amiodarone | en_US |
| dc.subject | economics | en_US |
| dc.subject | Death, Sudden, Cardiac | en_US |
| dc.subject | prevention & control | en_US |
| dc.subject | Health Care Costs | en_US |
| dc.subject | Treatment Outcome | en_US |
| dc.title | Cost effectiveness of the implantable cardioverter defibrillator | en_US |
| dc.type | text | en_US |
| Appears in Collections: | CHEPA Working Paper Series | |
Files in This Item:
There are no files associated with this item.
Items in MacSphere are protected by copyright, with all rights reserved, unless otherwise indicated.
